UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Cyclic sieving and orbit harmonics

Mathematische Zeitschrift, 2022, Vol.300 (1), p.639-660

2022

Volltextzugriff (PDF)

Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension

Scientific reports, 2022-05, Vol.12 (1), p.7393-7393, Article 7393

2022

Volltextzugriff (PDF)

A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.522

2024

Volltextzugriff (PDF)

A combinatorial model for the transition matrix between the Specht and $\operatorname {SL}_2$ -web bases

Forum of mathematics. Sigma, 2023-09, Vol.11

2023

Volltextzugriff (PDF)

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Experimental and Molecular Medicine, 2024, 56(0), , pp.570-582

2024

Volltextzugriff (PDF)

Clinical Evaluation of Digital Therapeutics: Present and Future

Healthcare Informatics Research, 2022, 28(3), , pp.188-197

2022

Volltextzugriff (PDF)

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration

Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (1), p.132

2023

Volltextzugriff (PDF)

Macdonald polynomials and cyclic sieving

European journal of combinatorics, 2022-03, Vol.101, p.103465, Article 103465

Oh, Jaeseong

2022

Volltextzugriff (PDF)

Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects

Frontiers in pharmacology, 2022-08, Vol.13, p.930615-930615

2022

Volltextzugriff (PDF)

A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study

PloS one, 2018-01, Vol.13 (1), p.e0191258

2018

Volltextzugriff (PDF)

Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report

Translational and Clinical Pharmacology, 2022, 30(2), , pp.83-86

2022

Volltextzugriff (PDF)

Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment

Frontiers in pharmacology, 2022-06, Vol.13, p.842836-842836

2022

Volltextzugriff (PDF)

Oral absorption of voriconazole is affected by SLCO2B1 c.396T>C genetic polymorphism in CYP2C19 poor metabolizers

The pharmacogenomics journal, 2020-12, Vol.20 (6), p.792-800

2020

Volltextzugriff (PDF)

Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans

Clinical and translational science, 2022-12, Vol.15 (12), p.2938-2946

2022

Volltextzugriff (PDF)

Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms

Clinical and translational science, 2023-11, Vol.16 (11), p.2177-2188

2023

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects

Clinical and translational science, 2023-07, Vol.16 (7), p.1163-1176

2023

Volltextzugriff (PDF)

A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine

npj vaccines, 2024-08, Vol.9 (1), p.140-7, Article 140

2024

Volltextzugriff (PDF)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses

Frontiers in pharmacology, 2023-04, Vol.14, p.1127932-1127932

2023

Volltextzugriff (PDF)

Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers

Clinical and translational science, 2023-03, Vol.16 (3), p.512-523

2023

Volltextzugriff (PDF)

Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects

Clinical and translational science, 2024-03, Vol.17 (3), p.e13744-n/a

2024

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study

Clinical and translational science, 2022-11, Vol.15 (11), p.2744-2757

2022

Volltextzugriff (PDF)

Adaptive design clinical trials: current status by disease and trial phase in various perspectives

Translational and Clinical Pharmacology, 2023, 31(4), , pp.202-216

2023

Volltextzugriff (PDF)

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects

Pharmaceutics, 2023-02, Vol.15 (2), p.549

2023

Volltextzugriff (PDF)

Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy

CPT: pharmacometrics and systems pharmacology, 2023-09, Vol.12 (9), p.1319-1334

2023

Volltextzugriff (PDF)

The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects

Clinical and translational science, 2022-09, Vol.15 (9), p.2116-2126

2022

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cyclic sieving and orbit harmonics

Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension

A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects

A combinatorial model for the transition matrix between the Specht and $\operatorname {SL}_2$ -web bases

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Clinical Evaluation of Digital Therapeutics: Present and Future

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration

Macdonald polynomials and cyclic sieving

Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects

A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study

Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report

Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment

Oral absorption of voriconazole is affected by SLCO2B1 c.396T>C genetic polymorphism in CYP2C19 poor metabolizers

Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans

Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects

A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses

Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers

Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study

Adaptive design clinical trials: current status by disease and trial phase in various perspectives

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects

Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy

The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects

Suchergebnisse filtern